CNCE Market Cap History



Below is a table of the CNCE market cap history going back to 2/13/2014:

Date CNCE Market Cap
2/13/2014229.97M
3/28/2014220.34M
5/13/2014186.16M
8/4/2014140.51M
11/6/2014261.52M
2/23/2015267.17M
5/6/2015320.61M
7/31/2015359.28M
10/30/2015501.52M
2/23/2016292.65M
4/29/2016309.70M
8/3/2016266.96M
11/3/2016167.28M
2/27/2017212.13M
4/28/2017358.07M
8/4/2017320.12M
11/6/2017377.80M
2/26/2018513.92M
5/1/2018430.48M
7/30/2018381.43M
10/29/2018353.55M
2/22/2019342.59M
4/30/2019244.63M
7/26/2019247.76M
11/4/2019152.34M
2/21/2020327.49M
4/24/2020338.64M
7/31/2020275.12M
10/30/2020316.30M
2/19/2021227.47M
4/26/2021144.14M
7/31/2021107.14M
11/5/2021127.20M
2/28/2022104.86M
5/2/2022114.44M
8/1/2022282.34M
11/1/2022283.31M

Also see: CNCE Shares Outstanding History
and CNCE YTD Return
CNCE Historical Market Cap:
+2.42% CAGR
CNCE Historical Market Cap: +2.42% CAGR

Mouse over chart for data details
2/13/2014 ...11/1/2022
Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products. We show 37 historical shares outstanding datapoints in our CNCE shares outstanding history coverage, used to compute CNCE market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CNCE market cap history over the course of time is important for investors interested in comparing CNCE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CNCE versus a peer is one thing; comparing CNCE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CNCE can fluctuate over the course of history. With this page we aim to empower investors researching CNCE by allowing them to research the CNCE market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CNCE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Concert Pharmaceuticals (CNCE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CNMD Market Cap History
CNSP Market Cap History
CNST Market Cap History
CNTX Market Cap History
CNVY Market Cap History
COCP Market Cap History
CODX Market Cap History
COGT Market Cap History
COLL Market Cap History
COM Market Cap History
More Healthcare companies »

 

CNCE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.